Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238073.RAvV3XhqiV6uAusq77_MBF6MbYcesLZvuqDU-yJcqnyZg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238073.RAvV3XhqiV6uAusq77_MBF6MbYcesLZvuqDU-yJcqnyZg130_assertion type Assertion NP1238073.RAvV3XhqiV6uAusq77_MBF6MbYcesLZvuqDU-yJcqnyZg130_head.
- NP1238073.RAvV3XhqiV6uAusq77_MBF6MbYcesLZvuqDU-yJcqnyZg130_assertion description "[This is the first study to date to examine global phosphorylation changes upon erlotinib treatment of lung adenocarcinoma cells and results from this study provide new insights into signaling downstream of mutant EGFRs in lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238073.RAvV3XhqiV6uAusq77_MBF6MbYcesLZvuqDU-yJcqnyZg130_provenance.
- NP1238073.RAvV3XhqiV6uAusq77_MBF6MbYcesLZvuqDU-yJcqnyZg130_assertion evidence source_evidence_literature NP1238073.RAvV3XhqiV6uAusq77_MBF6MbYcesLZvuqDU-yJcqnyZg130_provenance.
- NP1238073.RAvV3XhqiV6uAusq77_MBF6MbYcesLZvuqDU-yJcqnyZg130_assertion SIO_000772 25404012 NP1238073.RAvV3XhqiV6uAusq77_MBF6MbYcesLZvuqDU-yJcqnyZg130_provenance.
- NP1238073.RAvV3XhqiV6uAusq77_MBF6MbYcesLZvuqDU-yJcqnyZg130_assertion wasDerivedFrom befree-2016 NP1238073.RAvV3XhqiV6uAusq77_MBF6MbYcesLZvuqDU-yJcqnyZg130_provenance.
- NP1238073.RAvV3XhqiV6uAusq77_MBF6MbYcesLZvuqDU-yJcqnyZg130_assertion wasGeneratedBy ECO_0000203 NP1238073.RAvV3XhqiV6uAusq77_MBF6MbYcesLZvuqDU-yJcqnyZg130_provenance.